Cargando…

Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer

BACKGROUND: The study aimed to estimate the overall and disease-free survival rates of breast cancer patients and the factors affecting these rates. METHODS: In this retrospective study, data were obtained from 686 patients diagnosed with breast cancer in Sivas Cumhuriyet University Faculty of Medic...

Descripción completa

Detalles Bibliográficos
Autor principal: Zorlutuna, Şebnem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273498/
https://www.ncbi.nlm.nih.gov/pubmed/35866109
http://dx.doi.org/10.18502/ijph.v51i2.8690
_version_ 1784745089383268352
author Zorlutuna, Şebnem
author_facet Zorlutuna, Şebnem
author_sort Zorlutuna, Şebnem
collection PubMed
description BACKGROUND: The study aimed to estimate the overall and disease-free survival rates of breast cancer patients and the factors affecting these rates. METHODS: In this retrospective study, data were obtained from 686 patients diagnosed with breast cancer in Sivas Cumhuriyet University Faculty of Medicine Research and Application Hospital Oncology Center between 1988 and 2014. Total population sampling method was used. The survival rates at certain periods were determined by creating a Life Table. By using the Kaplan-Meier Analysis, the mean survival times and rates were determined, and whether the variables had an impact on survival was examined. By applying Cox regression analysis, the effect of prognostic factors that are significant on the survival time of breast cancer patients was examined. RESULTS: Overall mean survival time was found as 208.4±11.8 months. According to Kaplan-Meier analysis, 1, 5, 10 and 20-years overall survival rates were 96.6 ± 0.07%, 82.3 ± 1.7%, 64.4 ± 3.4% and 49%± 7.4%, respectively. According to Cox regression analysis results, variables that influence overall survival time were found as disease stage, multicentricity status, ECOG (performance status), presence of diabetes, CA15-3 value, neutro-phil/lymphocyte ratio. Moreover, variables that had an impact on the disease-free survival time were found as tumor grade, multicentricity, and ECOG. CONCLUSION: Many factors other than disease can prolong survival or accelerate death. Considering the findings of this study may be useful in planning the treatment of breast cancer patients have positive affect on overall survival rates.
format Online
Article
Text
id pubmed-9273498
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-92734982022-07-20 Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer Zorlutuna, Şebnem Iran J Public Health Original Article BACKGROUND: The study aimed to estimate the overall and disease-free survival rates of breast cancer patients and the factors affecting these rates. METHODS: In this retrospective study, data were obtained from 686 patients diagnosed with breast cancer in Sivas Cumhuriyet University Faculty of Medicine Research and Application Hospital Oncology Center between 1988 and 2014. Total population sampling method was used. The survival rates at certain periods were determined by creating a Life Table. By using the Kaplan-Meier Analysis, the mean survival times and rates were determined, and whether the variables had an impact on survival was examined. By applying Cox regression analysis, the effect of prognostic factors that are significant on the survival time of breast cancer patients was examined. RESULTS: Overall mean survival time was found as 208.4±11.8 months. According to Kaplan-Meier analysis, 1, 5, 10 and 20-years overall survival rates were 96.6 ± 0.07%, 82.3 ± 1.7%, 64.4 ± 3.4% and 49%± 7.4%, respectively. According to Cox regression analysis results, variables that influence overall survival time were found as disease stage, multicentricity status, ECOG (performance status), presence of diabetes, CA15-3 value, neutro-phil/lymphocyte ratio. Moreover, variables that had an impact on the disease-free survival time were found as tumor grade, multicentricity, and ECOG. CONCLUSION: Many factors other than disease can prolong survival or accelerate death. Considering the findings of this study may be useful in planning the treatment of breast cancer patients have positive affect on overall survival rates. Tehran University of Medical Sciences 2022-02 /pmc/articles/PMC9273498/ /pubmed/35866109 http://dx.doi.org/10.18502/ijph.v51i2.8690 Text en Copyright © 2022 Zorlutuna. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
Zorlutuna, Şebnem
Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer
title Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer
title_full Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer
title_fullStr Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer
title_full_unstemmed Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer
title_short Survival Rate and Prognostic Factors in Turkish Women Patients with Breast Cancer
title_sort survival rate and prognostic factors in turkish women patients with breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273498/
https://www.ncbi.nlm.nih.gov/pubmed/35866109
http://dx.doi.org/10.18502/ijph.v51i2.8690
work_keys_str_mv AT zorlutunasebnem survivalrateandprognosticfactorsinturkishwomenpatientswithbreastcancer